Portal de Periódicos da CAPES

Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models

2018; Cold Spring Harbor Laboratory Press; Volume: 8; Issue: 8 Linguagem: Inglês

10.1101/cshperspect.a030536

2472-5412

Gail P. Risbridger, Roxanne Toivanen, Renea A. Taylor,

Immunotherapy and Immune Responses

Gail P. Risbridger1,2,3, Roxanne Toivanen3,4 and Renea A. Taylor2,3 1Monash Partners Comprehensive Cancer Consortium, Melbourne, Victoria 3168, Australia 2Cancer Discovery Program, Biomedicine Discovery Institute; Prostate Cancer Research Group, Department of Anatomy and Developmental Biology; and Department of Physiology, Monash University, Melbourne, Victoria 3800, Australia 3Prostate Cancer Program, Cancer Research Division, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria 3000, Australia 4Departments of Medicine, Genetics & Development, Urology, and Systems Biology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York 10032 Correspondence: gail.risbridger{at}monash.edu